← back to search

Lior Z. Braunstein

Center for Cancer Research · US
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Biology, Medicine, Genetics, Breast cancer, Radiation therapy, and Oncology.
h-index
citations
3,134
works
18
NIH funding
primary concept
email

Recent publications

Large language model trained on clinical oncology data predicts cancer progression
npj Digital Medicine 2025cited by 16position: middledoi
NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer
Future Oncology 2025cited by 4position: firstdoi
Phase III Randomized Trial of Proton vs. Photon Therapy for Patients with Non-metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (Radcomp) Consortium Trial: Health-Related Quality of Life Outcomes
International Journal of Radiation Oncology*Biology*Physics 2025cited by 3position: middledoi
Automated real-world data integration improves cancer outcome prediction
Nature 2024cited by 140position: middledoi
A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008.
Journal of Clinical Oncology 2024cited by 7position: firstdoi
Abstract OT1-12-02: Preliminary report of the PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer
Cancer Research 2023cited by 14position: firstdoi
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
Nature Communications 2021cited by 94position: middledoi
Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer
Scientific Reports 2021cited by 53position: lastdoi
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Nature Genetics 2020cited by 727position: middledoi
Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium
Journal of Clinical Investigation 2020cited by 133position: middledoi
Clonal Hematopoiesis Before, During, and After Human Spaceflight
Cell Reports 2020cited by 62position: middledoi
Consensus on Contouring Primary Breast Tumors on MRI in the Setting of Neoadjuvant Partial Breast Irradiation in Trials
Practical Radiation Oncology 2020cited by 17position: middledoi
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma
Cancer Cell 2018cited by 262position: middledoi
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
Nature Genetics 2017cited by 546position: middledoi
Analysis of somatic microsatellite indels identifies driver events in human tumors
Nature Biotechnology 2017cited by 138position: middledoi
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
Nature Genetics 2016cited by 446position: middledoi
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair
Cell 2016cited by 441position: middledoi
Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin
Breast Cancer Research and Treatment 2015cited by 31position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2021–2025)Kelly L. Bolton · NYU Langone Health3 papers (2020–2025)Gad Getz · Broad Institute3 papers (2016–2017)Atanas Kamburov · Columbus McKinnon (United States)3 papers (2016–2017)Paz Polak · ID Genomics (United States)3 papers (2016–2017)Erica Stringer-Reasor · University of Alabama2 papers (2024–2025)Julia White · University of Miami2 papers (2024–2025)Alan D. D’Andrea · Broad Institute2 papers (2016–2017)William M. Sikov · Breast Center2 papers (2024–2025)Norman Wolmark · NRG Oncology2 papers (2024–2025)Simon N. Powell · Manhattan Scientifics (United States)2 papers (2021–2023)Hanna Bandos · NRG Oncology2 papers (2024–2025)Julian M. Hess · Broad Institute2 papers (2016–2017)Nicholas J. Haradhvala · Center for Cancer Research2 papers (2016–2017)Amnon Koren · Roswell Park Comprehensive Cancer Center2 papers (2016–2017)Michael S. Lawrence · Harvard University2 papers (2016–2017)Kent W. Mouw · Harvard University2 papers (2016–2017)Reshma Jagsi · Michigan Cancer Research Consortium2 papers (2024–2025)Eleftherios P. Mamounas · NRG Oncology2 papers (2024–2025)Thomas B. Julian · Cancer Institute (WIA)2 papers (2024–2025)